Ignite Creation Date:
2024-05-06 @ 10:31 AM
Last Modification Date:
2024-10-26 @ 12:31 PM
Study NCT ID:
NCT03272750
Status:
COMPLETED
Last Update Posted:
2017-09-06
First Post:
2017-09-01
Brief Title:
Evaluation of Tolerance and Trichological Efficacy of a Food Supplement
Sponsor:
Derming SRL
Organization:
Derming SRL
Study Overview
Official Title:
Controlled Randomized Double Blind Study for the Evaluation of Tolerance and Trichological Efficacy of a Food Supplement Bioscalin New Formulation Versus Reference Formulation Currently on the Market and Placebo
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Controlled randomized double blind study for the evaluation of tolerance and trichological efficacy of a food supplement Bioscalin new formulation versus reference formulation currently on the market and placebo
Detailed Description:
Aim of the study was to evaluate clinically and by non-invasive instrumental measurements the trichological activity of a food supplement taken for 3 months by subjects of both sexes aged between 18-60 years affected by telogen effluvium with a percentage of hair in anagen phase 75
In particular the study foresaw the evaluation of the trichological activity of the Bioscalin new formulation with Galeopsis Segetum in comparison to a reference product currently on the market and to placebo
It was also aim of this study to evaluate treatment tolerance
In particular the study foresaw the evaluation of the trichological activity of the Bioscalin new formulation with Galeopsis Segetum in comparison to a reference product currently on the market and to placebo
It was also aim of this study to evaluate treatment tolerance
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None